Amgen posted Q4 sales of $9.1 billion, up 11%, surpassing forecasts. EPS beat estimates, and analysts remain optimistic about growth prospects in 2025.

Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...

Product sales rose 11%, led by 14% volume growth. Products including Repatha, Blincyto and Tezspire all posted at least double digit sales growth, the company said. For the current year, Amgen expects ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

When is a sale not a sale? If a shop is advertising a sale, it has to comply with requirements set out in the Consumer Protection from Unfair Trading Regulations 2008. Government guidelines set out ...

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human ...

Among the 10 drugs listed, Medicare Part D spent the most on Ozempic, Rybelsus and Wegovy, at $14.43 billion, according to a CMS fact sheet on Friday ... medication's U.S. sales or pull all ...

Dollar set for losing week; sterling falls further after retail sales By Investing.com - Jan 17, 2025 Investing.com - The US dollar edged higher Friday, but was on course for a weekly loss after ...

SEE: PowerShell: A cheat sheet (free PDF) (TechRepublic) TechRepublic is able to offer our services for free because some vendors may pay us for web traffic or other sales opportunities.